Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

[Biologic modulation of ionizing radiation by Toll-like receptors agonists: towards an increase in the therapeutic index of radiotherapy?].

Riou O, Azria D, Larbouret C, Robert B.

Bull Cancer. 2012 May;99(5):545-50. doi: 10.1684/bdc.2012.1578. Review. French.

2.

An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models.

Burdelya LG, Krivokrysenko VI, Tallant TC, Strom E, Gleiberman AS, Gupta D, Kurnasov OV, Fort FL, Osterman AL, Didonato JA, Feinstein E, Gudkov AV.

Science. 2008 Apr 11;320(5873):226-30. doi: 10.1126/science.1154986.

3.

Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer.

Roses RE, Xu M, Koski GK, Czerniecki BJ.

Oncogene. 2008 Jan 7;27(2):200-7. doi: 10.1038/sj.onc.1210909. Review.

PMID:
18176601
4.

Autophagy and toll-like receptors: a new link in cancer cells.

Bertin S, Pierrefite-Carle V.

Autophagy. 2008 Nov;4(8):1086-9. Epub 2008 Nov 6.

PMID:
18927486
5.

Radiotherapy and toll-like receptor agonists.

Marabelle A, Filatenkov A, Sagiv-Barfi I, Kohrt H.

Semin Radiat Oncol. 2015 Jan;25(1):34-9. doi: 10.1016/j.semradonc.2014.07.006. Review.

PMID:
25481264
6.

Harnessing the power of bacteria to protect the gut.

Abreu MT.

N Engl J Med. 2008 Aug 14;359(7):756-9. doi: 10.1056/NEJMcibr0804223. No abstract available.

PMID:
18703481
7.

Immunomodulatory effects of radiation: what is next for cancer therapy?

Kumari A, Simon SS, Moody TD, Garnett-Benson C.

Future Oncol. 2016 Jan;12(2):239-56. doi: 10.2217/fon.15.300. Epub 2015 Dec 1. Review.

8.

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.

Kanzler H, Barrat FJ, Hessel EM, Coffman RL.

Nat Med. 2007 May;13(5):552-9. Review.

PMID:
17479101
9.

Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.

Merlo A, Calcaterra C, Mènard S, Balsari A.

J Leukoc Biol. 2007 Sep;82(3):509-18. Epub 2007 Jun 22.

PMID:
17586660
10.

Profile of Toll-like receptor expressions and induction of nitric oxide synthesis by Toll-like receptor agonists in chicken monocytes.

He H, Genovese KJ, Nisbet DJ, Kogut MH.

Mol Immunol. 2006 Mar;43(7):783-9. Epub 2005 Aug 10.

PMID:
16098593
11.

Radioprotective effects of Aegle marmelos (L.) Correa (Bael): a concise review.

Baliga MS, Bhat HP, Pereira MM, Mathias N, Venkatesh P.

J Altern Complement Med. 2010 Oct;16(10):1109-16. doi: 10.1089/acm.2009.0604. Epub 2010 Oct 9. Review.

PMID:
20932194
12.

Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.

Mason KA, Ariga H, Neal R, Valdecanas D, Hunter N, Krieg AM, Whisnant JK, Milas L.

Clin Cancer Res. 2005 Jan 1;11(1):361-9.

13.

Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.

Krieg AM, Vollmer J.

Immunol Rev. 2007 Dec;220:251-69. Review.

PMID:
17979852
14.

The role of pentoxifylline as a modifier of radiation therapy.

Nieder C, Zimmermann FB, Adam M, Molls M.

Cancer Treat Rev. 2005 Oct;31(6):448-55. Epub 2005 Oct 12. Review.

PMID:
16225996
15.

[Angiogenesis inhibitors and radiation therapy: from biology to clinical practice].

Mazeron R, Azria D, Deutsch E.

Cancer Radiother. 2009 Oct;13(6-7):568-73. doi: 10.1016/j.canrad.2009.06.015. Epub 2009 Aug 19. Review. French.

PMID:
19695932
16.
17.

Human monocytoid cells as a model to study Toll-like receptor-mediated activation.

Remer KA, Brcic M, Sauter KS, Jungi TW.

J Immunol Methods. 2006 Jun 30;313(1-2):1-10. Epub 2006 Apr 25.

PMID:
16720029
18.

A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy.

Feng M, Smith DE, Normolle DP, Knol JA, Pan CC, Ben-Josef E, Lu Z, Feng MR, Chen J, Ensminger W, Lawrence TS.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1441-7. doi: 10.1016/j.ijrobp.2011.10.020. Epub 2012 Mar 21.

19.

Toll-like receptors as therapeutic targets for cancer.

Holldack J.

Drug Discov Today. 2014 Apr;19(4):379-82. doi: 10.1016/j.drudis.2013.08.020. Epub 2013 Sep 3.

PMID:
24012797
20.

Immunological aspects of local radiotherapy: clinical relevance.

Formenti SC.

Discov Med. 2010 Feb;9(45):119-24. Review.

Supplemental Content

Support Center